Skip to main content
SpringerLink
Log in

Design and Synthesis of Polymer Prodrugs for Improving Water-Solubility, Pharmacokinetic Behavior and Antitumor Efficacy of TXA9

  • RESEARCH PAPER
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

TXA9, a novel cardiac glycoside, has a potent anti-proliferative effect against A549 human lung cancer cells, however, possesses a poor water-solubility and a rapid metabolic rate in vivo which limited the further development of TXA9. To overcome the shortcomings of TXA9, four polymer prodrugs of TXA9 were designed and synthesized.

Methods

Poly (ethylene glycol) monomethyl ether (mPEG) and α-tocopherol polyethylene glycol succinate (TPGS) were applied to modify TXA9 via carbonate ester and glycine linkers respectively to obtain four polymer prodrugs. The water-solubility and stability of prodrugs were studied in vitro while their pharmacokinetic behaviors and antitumor activity were investigated in vivo.

Results

The water-solubility of TXA9 was obviously increased and prodrugs with glycine linkers showed a better stability in rat plasma. Their pharmacokinetic investigation found that the t1/2 and AUC0-∞ of TPGS-Gly-TXA9 was increased by 80- and 9.6-fold compared with that of TXA9, which was more superior than the other three prodrugs. More importantly, the tumor inhibition rate of TPGS-Gly-TXA9 (43.81%) on A549 xenograft nude mice was significantly increased compared with that of TXA9 (25.26%).

Conclusion

The above results suggested that TPGS-Gly-TXA9 possessed better antitumor efficiency than TXA9 and could be further investigated as an anti-cancer agent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

DCC:

N, N’-dicyclohexylcarbodiimide

DMAP:

4-Dimethylaminopyridine

EDCI:

1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride

EPR:

Enhanced permeability and retention

mPEG:

Poly (ethylene glycol) monomethyl ether

NSCLC:

Non-small-cell lung cancer

PEG:

Polyethylene glycol

pNPC:

p-Nitrophenyl chloroformate

TPGS:

α-Tocopherol polyethylene glycol succinate

References

  1. Stewart BW, Wild CP. World Cancer report. International Agency for Research on Cancer 2014.

  2. Oser MG, Niederst MJ, Sequist LV, Engelman JA. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol. 2015;16(4):e165–72.

    Article  CAS  Google Scholar 

  3. Xue R, Han N, Xia MY, Ye C, Hao ZH, Wang LH, et al. TXA9, a cardiac glycoside from Streptocaulon juventas , exerts a potent anti-tumor activity against human non-small cell lung cancer cells in vitro and in vivo. Steroids. 2015;94(23):51–9.

    Article  CAS  Google Scholar 

  4. Ye C, Wang H, Xue R, Han N, Wang LH, Yang JY, et al. Minor cytotoxic cardenolide glycosides from the root of Streptocaulon juventas. Steroids. 2015;93:39–46.

    Article  CAS  Google Scholar 

  5. Greenwald RB, Yun HC, Mcguire J, Conover CD. Effective drug delivery by PEGylated drug conjugates. Adv Drug Deliv Rev. 2003;55(2):217–50.

    Article  CAS  Google Scholar 

  6. Banerjee SS, Aher N, Patil R, Khandare J. Poly(ethylene glycol)-Prodrug conjugates: concept, design, and applications. J Drug Deliv. 2012;2012:1–17.

    Article  Google Scholar 

  7. Zhang ZP, Tan SW, Feng SS. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials. 2012;33(19):4889–906.

    Article  CAS  Google Scholar 

  8. Greenwald RB, Gilbert CW, Pendri A, Conover CD, Xia J, Martinez A. Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness. J Med Chem. 1996;39(2):424–31.

    Article  CAS  Google Scholar 

  9. Sun HP, Zhang Q, Zhang Z, Tong J, Chu DF, Gu JK. Simultaneous quantitative analysis of Polyethylene Glycol (PEG), PEGylated paclitaxel and paclitaxel in rats by MS/MSALL technique with hybrid quadrupole time-of-flight mass spectrometry. J Pharm Biomed Anal. 2017;145:255–61.

    Article  CAS  Google Scholar 

  10. Ding Y, Zhang P, Tang XY, Zhang C, Ding S, Ye H, et al. PEG prodrug of gambogic acid: amino acid and dipeptide spacer effects. Polymer. 2012;53(8):1694–702.

    Article  CAS  Google Scholar 

  11. Zhao YJ, Wei W, Su ZG, Ma GH. Poly (ethylene glycol) prodrug for anthracyclines via N-Mannich base linker: design, synthesis and biological evaluation. Int J Pharm. 2009;379(1):90–9.

    Article  CAS  Google Scholar 

  12. Rowinsky EK, Rizzo J, Ochoa L, Takimoto CH, Forouzesh B, Schwartz G, et al. A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignancies. J Clin Oncol. 2003;21(1):148–57.

    Article  CAS  Google Scholar 

  13. Liu T, Yuan X, Jia TT, Liu C, Ni ZH, Qin ZL, et al. Polymeric prodrug of bufalin for increasing solubility and stability: synthesis and anticancer study in vitro and in vivo. Int J Pharm. 2016;506(1–2):382–93.

    Article  CAS  Google Scholar 

  14. Cao N, Feng SS. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation. Biomaterials. 2008;29:3856–65.

    Article  CAS  Google Scholar 

  15. Bao YL, Guo YY, Zhuang XT, Li D, Cheng BL, Tan SW, et al. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Mol Pharm. 2014;11(9):3196–209.

    Article  CAS  Google Scholar 

  16. Anbharasi V, Cao N, Feng SS. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy. J Biomed Mater Res A. 2010;94A(3):730–43.

    CAS  Google Scholar 

  17. Lu L, Yan Z, Weng S, Zhu W, Qin L. Complete regression of xenograft tumors using biodegradable mPEG-PLA-SN38 block copolymer micelles. J Colloids Surf B Biointerfaces. 2016;142:417–23.

    Article  CAS  Google Scholar 

  18. Wei Z, Hao J, Yuan S, Li Y, Juan W, Sha X, et al. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm. 2009;376(1–2):176–85.

    Article  CAS  Google Scholar 

  19. Hu X, Liu RL, Zhang D, Zhang J, Li ZH, Luan YX. Rational design of an amphiphilic chlorambucil prodrug realizing self-assembled micelles for efficient anticancer therapy. ACS Biomater Sci Eng. 2018;4:973–980.

  20. Lommerse J P M, Price S L, Taylor R. Hydrogen bonding of carbonyl, ether, and ester oxygen atoms with alkanol hydroxyl groups. J Comput Chem. 1997;18(6):757–774.

  21. Hao T, Chen D, Liu K, Qi Y, Li Z. Micelles of d-α-tocopheryl polyethylene glycol 2000 succinate (TPGS 2K) for doxorubicin delivery with reversal of multidrug resistance. ACS Appl Mater Interfaces. 2015;7(32):18064–75.

    Article  CAS  Google Scholar 

  22. Vig BS, Huttunen KM, Laine K, Rautio J. Amino acids as promoieties in prodrug design and development. Adv Drug Deliv Rev. 2013;65(10):1370–85.

    Article  CAS  Google Scholar 

  23. Pasut G, Veronese FM. Polymer–drug conjugation, recent achievements and general strategies. Prog Polym Sci. 2007;32(8):933–61.

    Article  CAS  Google Scholar 

  24. Roy HK, DiBaise JK, Black J, Karolski WJ, Ratashak A, Ansari S. Polyethylene glycol induces apoptosis in HT-29 cells: potential mechanism for chemoprevention of colon cancer. FEBS Lett. 2001;496(2–3):143–6.

    Article  CAS  Google Scholar 

  25. Veronese FM, Schiavon O, Pasut G, Mendichi R, Andersson L, Tsirk A, et al. PEG-doxorubicin conjugates:influence of polymer structure on drug release,in vitro cytotoxicity,biodistribution,and antitumor activity. Bioconjug Chem. 2005;16(4):775–84.

    Article  CAS  Google Scholar 

  26. Lu B, Huang D, Zheng H, Huang ZJ, Xu PH, Xu HX, et al. Preparation, characterization, and in vitro efficacy of O-carboxymethyl chitosan conjugate of melphalan. Carbohydr Polym. 2013;98(1):36–42.

    Article  CAS  Google Scholar 

  27. Sun JJ, Liu YH, Chen YC, Zhao WC, Zhai QY, Rathod S, et al. Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy. J Control Release. 2017;258:43–55.

    Article  CAS  Google Scholar 

  28. Sun X, Guowei W, Hao Z, Shiqi H, Xin L, Jianbin T, et al. The blood clearance kinetics and pathway of polymeric micelles in cancer drug delivery. ACS Nano. 12:6179–92.

  29. Li M, Liang Z, Sun X, Gong T, Zhang Z. A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier. PLoS One. 2014;9(11):e112888.

  30. Luo C, Sun J, Liu D, Sun BJ, Lei M, Musetti S, et al. Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy. Nano Lett. 2016;16(9):5401–8.

    Article  CAS  Google Scholar 

  31. Webb BA, Chimenti M, Jacobson MP, Barber DL. Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer. 2011;11(9):671–7.

    Article  CAS  Google Scholar 

  32. Prasad KN, Kumar B, Yan XD, Hanson AJ, Cole WC. α-Tocopheryl succinate, the Most effective form of vitamin E for adjuvant Cancer treatment: a review. J Am Coll Nutr. 2003;22(2):108–17.

    Article  CAS  Google Scholar 

  33. Shanker M, Gopalan B, Patel S, Bocangel D, Chada S, Ramesh R. Vitamin E succinate in combination with mda-7 results in enhanced human ovarian tumor cell killing through modulation of extrinsic and intrinsic apoptotic pathways. Cancer Lett. 2007;254:217–26.

    Article  CAS  Google Scholar 

  34. Pathak AK, Singh N, Khanna N, Reddy VG, Prasad KN, Kochupillai V. Potentiation of the effect of paclitaxel and carboplatin by antioxidant mixture on human lung Cancer H520 cells. J Am Coll Nutr. 2002;21(5):416–21.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Traditional Chinese Material, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, 110016, China

    Yiwen Li, Chun Ye, Chengcheng Cai, Meng Zhao, Na Han, Zhihui Liu, Jianxiu Zhai & Jun Yin

Authors
  1. Yiwen Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chun Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chengcheng Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Meng Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Na Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhihui Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jianxiu Zhai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jun Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Yin.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

ESM 1

(DOCX 17393 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Y., Ye, C., Cai, C. et al. Design and Synthesis of Polymer Prodrugs for Improving Water-Solubility, Pharmacokinetic Behavior and Antitumor Efficacy of TXA9. Pharm Res 37, 66 (2020). https://doi.org/10.1007/s11095-020-02789-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11095-020-02789-w

Key Words

Search

Navigation